A

Attovia Therapeutics Inc
D

ATTO

22.420
USD
-0.27
(-1.19%)
مغلق
حجم التداول
4,324
الربح لكل سهم
-10
العائد الربحي
-
P/E
-14
حجم السوق
1,023,501,294
المقالات
المزيد

العنوان: Attovia Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.